atherectomy devices market research report

Atherectomy Devices Market - Global Outlook and Forecast 2020-2025

PUBLISHED DATE : Mar 2020 | Pages : 229

Up to $1650 off Untill Oct 2020

GLOBAL ATHERECTOMY DEVICES MARKET SIZE TO CROSS USD 1.2 BILLION BY 2025, GROWING AT A CAGR OF 7% DURING THE FORECAST PERIOD

Atherectomy Devices Market Size, Share, Trends, Analysis Report by Procedure (Directional, Rotational, Orbital, and Laser), End-user (Hospitality, Specialty Cardiac Centers, ASCs, and Office-Based Cath Labs), Application (Peripheral Arterial Disease and Coronary Arterial Disease), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Market Share & Forecast, 2020–2025

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Customize this Report

Most Exhaustive Report

229 Pages

28 Tables

123 Charts

5 Regions

17 Countries

9 Companies

4 Market Segment

ATHERECTOMY DEVICES MARKET REPORT SCOPE

Report Attribute Details
Market Size (rEVENUE) USD 1.2 BILLION (2025)
CAGR 7% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Procedure (Directional, Rotational, Orbital, and Laser), End-user (Hospitality, Specialty Cardiac Centers, ASCs, and Office-Based Cath Labs), Application (Peripheral Arterial Disease and Coronary Arterial Disease)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, Germany, France, UK, Spain, Italy, Japan, China, Australia, South Korea, India, Brazil, Mexico, Argentina, Turkey, and Saudi Arabia

INDUSTRY INSIGHTS

The global atherectomy devices market size to cross USD 1.2 billion by 2025, growing at a CAGR of over 7% during the forecast period. The atherectomy devices market is likely to witness significant growth on account of the increasing prevalence of coronary artery disease (CAD) and peripheral artery disease (PAD). Cardiovascular diseases (CVDs) such as CAD and PAD are among the leading causes of death globally. Several factors, which include the growth in the aging population, the rise in diabetes and other lifestyle diseases, and the increase in the percentage of smokers, are expected to contribute to the growth of CVDs, which is likely to increase the demand for the devices.

The increasing use of laser atherectomy as a preferred option for patients with high surgical risk because of poor underlying physiology or complex lesion anatomy is expected to drive the market.  Furthermore, the laser systems operate over any guidewire, which is not possible with the other systems. Hence, the presence of several substantial benefits and the rising demand for advanced treatment for CAD and PAD is driving several market players to focus on the development and commercialization of laser devices. Therefore, the availability of advanced technological features and improved cost-effective clinical outcomes laser devices are projected to boost the global atherectomy devices market during the forecast period.

SNIPPETS

  • The PAD application segment is likely to witness an absolute growth of over 50% during the forecast period. The growth is due to the high adoption of atherectomy devices for the efficient and safe treatment of PAD.
  • In the US, CADs are expected to cause over 350,000 deaths annually, and the disease is recognized as the leading cause of death globally, which is likely to propel the demand.
  • The elderly population is highly prone to CVDs, especially in developing countries. In China, the number of people above 60 years is expected to reach over 430 million by 2050, thereby boosting the prospects of the market.

ATHERECTOMY DEVICES MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Procedures
  • End-user
  • Applications
  • Geography

INSIGHTS BY PROCEDURES 

The directional atherectomy segment is growing at a healthy rate. The growth can be attributed to the growing patient population with PAD and CAD. Arterial diseases remain increasingly common disorders and continue to be a major cause of chronic morbidities worldwide. Moreover, promising clinical outcomes of directional procedures for vein graft stenosis is another factor for the growth of the segment.

Orbital atherectomy is a promising new methodology mainly for treating various arterial diseases, including both CAD and PAD. With the aging population worldwide, and the increasing risk of coronary and peripheral artery calcification, the number of surgical procedures for the treatment of arterial plaque is growing at a steady rate. Therefore, the uptake for orbital devices is growing, contributing to future market growth. Further, low procedural complications and low rates of restenosis have led to increased demand for orbital devices.

INSIGHTS BY END-USER 

Patients increasingly prefer to treat diagnosed CVDs in specialty cardiac centers over hospitals as these centers provide specialized cardiac healthcare services to patients. The segment is expected to grow at a significant rate due to the availability of sophisticated infrastructure related to the diagnosis and treatment of CVDs in standalone cardiology centers compared to hospitals. However, the hospital segment is likely to dominate the atherectomy devices market shares due to favorable reimbursement policies and the availability of skilled healthcare professionals. Ambulatory surgery centers (ASCs) are cost-effective and offer high-quality care with the minimal indirect cost of treatment. ASCs provide advanced operating equipment, specialist surgeons, and well-equipped operating rooms without complex administrative procedures, and such factors are likely to bolster the segment growth. Further, ASCs are expected to witness major growth in developed countries as the end-users focus is increasingly shifting from open cardiovascular surgical techniques to percutaneous-based techniques.

INSIGHTS BY APPLICATION  

With the rising burden of PAD globally, minimally invasive endovascular treatments such as atherectomy are growing compared to conventional procedures. Moreover, an atherectomy is specifically effective for treating blockages in arteries that happen around branches or in vessels that cannot be treated easily with stents or balloon angioplasty. Hence, their increased application for treating PAD is driving the uptake of these devices across the globe.

The CAD segment is expected to bolster the demand for atherectomy devices on account of the increasing prevalence of CVDs such as CAD. Atherectomy is an advanced treatment option that helps to treat heavily calcified lesions and complex vessel diseases. Hence, these procedures are increasingly replacing balloon angioplasty, which is likely to drive growth.

INSIGHTS BY GEOGRAPHY 

North America is expected to grow at a significant rate due to the increasing preference for minimally invasive surgical procedures. The presence of a large patient pool of PAD and CAD population with increasing adoption of atherectomy devices is likely to drive the market. Further, the demand in the region is expected to be driven by favorable reimbursement policies, technological advancements, and the extensive reach of innovative products. The European market is likely to grow due to the presence of sophisticated healthcare infrastructure, high awareness regarding the availability of advanced devices, and increased inclination toward minimally invasive surgical approach. Germany, France, UK, Spain, and Italy are the major revenue contributors in the European market. The highest proportion of people with an increased incidence of CAD and PAD is likely to drive the APAC market. Other factors, such as socioeconomic changes, unhealthy diet, smoking, liquor intake, and demographic aging are expected to fuel the demand in the region.

INSIGHTS BY VENDORS

The global atherectomy devices market is moderately competitive and characterized by the presence of a few players. The market is expected to witness rapid technological advancements and new product launches. The key players are facing competition within themselves, and other prominent players are likely to compete by launching technologically advanced devices such as image-guided and laser systems. Multiple product launches, diversified product portfolio, and investment in R&D activities are expected to be key factors for companies to maintain revenue growth during the forecast period.

The atherectomy devices market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Procedure

  • Directional Atherectomy
  • Rotational Atherectomy
  • Orbital Atherectomy
  • Laser Atherectomy

By End-user 

  • Hospitals
  • Specialty Cardiac Centers
  • ASCs
  • Office-based Cath Labs

By Application  

  • Peripheral Arterial Disease (PAD)
  • Coronary Arterial Disease (CAD)

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • APAC
    • Japan
    • China
    • Australia
    • South Korea
    • India
  • Middle East & Africa
    • Turkey
    • Saudi Arabia

Frequently Asked Questions

The atherectomy devices market size to reach revenues of $1.2 billion, growing at a CAGR of over 7% during 2019-2025.
The European market is likely to grow due to the presence of sophisticated healthcare infrastructure, high awareness regarding the availability of advanced devices, and increased inclination toward minimally invasive surgical approach.
The highest proportion of people with an increased incidence of CAD and PAD is likely to drive the APAC market.
The hospital segment is likely to dominate the atherectomy devices market shares due to favorable reimbursement policies and the availability of skilled healthcare professionals.
The leading vendors in the atherectomy devices market are Cardiovascular Systems, Medtronic, Koninklijke Philips, and Boston Scientific. The global atherectomy devices market is moderately competitive and characterized by the presence of a few players.
Read More

Select a license type that suits your business needs

Single User Licence
$2345.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$2680.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$3350.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1005.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

Our Clients

33%

Off

OFF

DAYS

HOURS

MINUTES

SECONDS

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date